다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Magenta Therapeutics Inc (MGTA)
Magenta Therapeutics Inc (MGTA) 뉴스

MGTA

Magenta Therapeutics (MGTA)

Magenta Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:MGTA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:27	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/10	05:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/05/10	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/12	05:10	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/12	05:09	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/12	05:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/02	07:34	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/04/02	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/28	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	06:10	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	06:02	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	05:07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/03/22	05:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/02/15	06:16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/02/10	06:10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/02/08	06:52	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/02/03	06:32	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/02/01	02:11	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/27	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/27	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/27	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/25	08:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/25	07:26	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/22	21:34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2024/01/08	22:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2023/12/22	07:08	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MGTA	Magenta Therapeutics Inc
2023/12/22	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2023/11/10	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2023/11/10	06:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc
2023/10/26	05:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MGTA	Magenta Therapeutics Inc

검색 관련기사 보기:NASDAQ:MGTA

1 2 3 4 5 6 7 8 9 10 다음 >>

Digital Health Acquisition

Jpm Ch Cbtr Etf

New Providence Acquisiti...

Harbor International Com...

Vontobel Financial Produ...

Glencore Xstrata (PK)

L&G Global Brands UCITS ...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관